Dysphagia as a symptom of an adverse effect of anticoagulant therapy
Renata Kolářová1
+ Affiliation
Summary
This case report presents an unusual side effect of dabigatran that can lead to drug-related esophageal mucosal involvement, known as dabigatran-induced esophagitis, manifested by dysphagic problems and typical endoscopic findings, especially in predisposed patients. After discontinuation of dabigatran, clinical problems rapidly resolved and endoscopic findings normalized.
Keywords
dabigatran, dysphagia, esophagitisTo read this article in full, please register for free on this website.
Benefits for subscribers
Benefits for logged users
Literature
1. Duda M, Hildebrand T. Jícen a kardie. In: Mařatka Z et al. Gastroenterologie. 1. vyd. Praha: Karolinum 1999: 53–54.
2. Ootani A, Hayashi Y, Miyagi Y. Dabigatran-induced esophagitis. Clin Gastroenterol Hepatol 2014; 12 (7): e55–e56. doi: 10.1016/j.cgh.2013.09.010.
3. Matsuura H, Suto K, Yasuhara H et al. Longitudinal sloughing mucosal casts: dabigatran-induced oesophagitis. Eur Heart J 2018; 39 (36): 3400. doi: 10.1093/eurheartj/ehy538.
4. Singh S, Savage L, Klein M et al. Severe necrotic oesophageal and gastric ulceration associated with dabigatran. BMJ Case Rep 2013. bcr2013009139. doi: 10.1136/bcr-2013-009139.
5. Wood M, Shaw P. Pradaxa-induced esophageal ulcer. BMJ Case Rep 2015. bcr2015211371. doi: 10.1136/bcr-2015-211371.
6. Kajihara Y. Dabigatran-induced esophagitis. Cleve Clin J Med 2019; 86 (5): 303–304. doi: 10.3949/ccjm.86a.18117.
7. Kajihara Y. Exfoliative esophagitis. Eur J Intern Med 2018; 53: e1. doi: 10.1016/j.ejim.2017.12. 013.
8. European Medicine Agency. SPC Pradaxa. [online]. Dostupné na: https: //www.ema.europa.eu/en/documents/product-information/pradaxa-epar-product-information_cs.pdf.
9. Nyuzuki S, Yamakawa R, Kawauchi K et al. Clinical study of esophagitis induced by dabigatran. [online]. Available from: https: //cdn.ueg.eu/uegfolga-web/uegf-ep-mat088/P1039.pdf.
10. Toya Y, Nakamura S, Tomita K et al. Dabigatran-induced esophagitis: the prevalence and endoscopic characteristics. J Gastroenterol Hepatol 2016; 31 (3): 610–614. doi: 10.1111/jgh.13 024.
11. Katzka DA. Esophageal disorders caused by medications, trauma, and infection. In: Feldman M, Friedman LS, Brandt LJ (eds). Sleisenger and Fordtran’s gastrointestinal and liver disease. 9th ed. Philadelphia: Saunders/Elsevier 2010: 735–737.